Do you perform PRK over previous LASIK? If so, what technique do you use, and what
By SANDY T. FELDMAN, MD; Louis E. Probst, MD; William B. Trattler, MD; and Stephen A. Updegraff, MD
By William B. Trattler, MD
By Malaika David, Associate Editor
The surgeon who received the 2009 Innovator’s Award from the ASCRS and the AAO’s Kelman Award shares his picks from last year.
By Robert H. Osher, MD
By Kevin J. Denny, MD; Jeremy Z. Kieval, MD; Kevin M. Miller, MD; and Michael Wong, MD
By Mitchell A. Jackson, MD, and James S. Lewis, MD
Two surgeons discuss the creation of the LASIK flap.
By Mark E. Johnston, MD, FRCSC, and L. Shawn Wong, MD
Common sense in the face of a complication will nearly always ensure an excellent outcome.
By Richard Foulkes, MD
By Uday Devgan, MD; Michael Ehrenhaus, MD; and Warren E. Hill, MD
It’s all relative.
By John F. Doane, MD, and James A. Denning
Each surgeon must determine the approach to premium-channel IOL surgery that will work for him or her.
By J. E. “Jay” McDonald II, MD
Making a good thing even better: a primer for cataract surgeons.
By Jonathan H. Talamo, MD
Advice for getting started.
By Louis D. “Skip” Nichamin, MD
Ophthalmologists can expect to see new technology in the next decade.
By Mark Packer, MD
A preview of today’s new products
Dr. Henderson discusses challenging cases, women in ophthalmology, and her personal goals.
Trainees share their experiences.
By Elsie Chan, MBBS; Guenal Kahraman, MD; Leonoor S. Koetsier, MD; Eugene Y.J. Ng, MRCOPHTH; and Charl G. Weitz, MBCHB
Bausch + Lomb (Rochester, NY) announced the worldwide launch of its Crystalens Aspheric Optic (AO) IOL. The Crystalens AO was recently approved by the FDA and is the first aberration-free accommodating IOL with aspheric optics... more >
PixelOptics, Inc. (Roanoke, VA), and Panasonic Shikoku Electronics Co., Ltd (Matsuyama, Japan), have collaborated on the development of PixelOptics’ electronic eyeglasses. PixelOptics announced its plan to market and sell bot... more >
EyeGate Pharmaceuticals, Inc. (Waltham, MA), said that it will use funding secured in series D venture financing to continue development of EGP-437, a dexamethasonederived corticosteroid solution, for the treatment of dry eye. ... more >
In a move to diversify its business and gain ground in the rapidly growing global eye care business, Novartis AG (Basel, Switzerland) announced in January a deal to purchase a majority stake in Alcon, Inc. (Huenenberg, Switzer... more >
Advertisement
A preview of an ongoing US clinical trial for topography-guided customized ablations.
By R. Doyle Stulting, MD, PhD
By Malaika David, Associate Editor
Ophthalmologists can expect to see new technology in the next decade.
By Mark Packer, MD
By Uday Devgan, MD; Michael Ehrenhaus, MD; and Warren E. Hill, MD
It’s all relative.
By John F. Doane, MD, and James A. Denning